This announcement is a separate document:
自愿披露关于口服PROTAC药物HP518片中国临床试验完成首例受试者入组的公告
Voluntary disclosure announcement on completion of the first clinical trial of the oral PROTAC drug HP518 tablets in China
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.